Higher abundance of PrP has been detected in a variety of human cancers, and higher expression has been correlated with poorer prognosis in patients with PDAC, gastric cancer, melanoma, and colon cancer (8, 11, 29, 30, 31, 32, 33, 34, 35, 36, 37). Here, PRNP is linked to colonic neoplasm.